Methallylescaline

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Methallylescaline
Methallylescaline.png
Names
IUPAC name
2-{3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethanamine
Identifiers
  • 207740-41-8 ☑Y
3D model (JSmol)
  • Interactive image
ChEMBL
  • ChEMBL126803 ☑Y
ChemSpider
  • 21106346 ☑Y
Properties
C14H21NO3
Molar mass 251.33 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☑Y verify (what is ☑Y☒N ?)
Infobox references

Methallylescaline (4-methylallyloxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. It is also the 4-methyl analog of allylescaline. Methallylescaline was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 40–65 mg and the duration is listed as 12–16 hours.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of methallylescaline.

Legal status

Allylescaline is illegal in Sweden as of 26 January 2016.[2]

See also

References

  1. ^ Methallylescaline entry in PiHKAL
  2. ^ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Methallylescaline&oldid=832897081"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/Methallylescaline
This page is based on the copyrighted Wikipedia article "Methallylescaline"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA